The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
Abstract
Chronic kidney disease (CKD) is a worldwide public health problem associated with a high prevalence of cardiovascular disease (CVD) and impaired quality of life. Previous research for preventing loss of glomerular filtration rate (GFR) has focused on reducing blood pressure (BP) and proteinuria. Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists (ARB) are commonly used in patients with early CKD, but their value in advanced CKD (estimated GFR (eGFR) ≤30 ml/min/1.73 m 2) is unknown. There remains a debate about the omission of ACEi/ARB in patients with advanced CKD and their use in association with CVD or heart failure. Does the potential gain in eGFR with ACEi/ARB cessation outweigh the potential adverse cardiovascular outcomes? This paper reviews the current literature that addresses this issue. Several controversies are discussed. Although lowering BP reduces cardiovascular events, evidence suggests that ACEi/ARBs are not superior to other antihypertensive agents. There are no studies assessing the benefits of ACEi/ARB therapy in cardiovascular risk reduction in advanced non-dialysis CKD. The STOP ACEi trial will strengthen the evidence base and shed light on the potential merits and dangers of ACEi/ARB use in advanced CKD on renal function and cardiovascular outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
Clinical epidemiology of cardiovascular disease in chronic renal disease
Foley, R., Parfrey, P., & Sarnak, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,958
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479
(2000) · PubMed · Cited by 2,095
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
Jamerson, K., Weber, M. A., Bakris, G. L., Dahlöf, B., Pitt, B., Shi, V., Hester, A., Gupte, J., Gatlin, M., & Velazquez, E. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806182 · Cited by 2,065
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Pitt, B., Poole-Wilson, P. A., Segal, R., Martinez, F. A., Dickstein, K., Camm, A. J., Konstam, M. A., Riegger, G., Klinger, G. H., Neaton, J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02213-3 · Cited by 1,961
Left Ventricular Remodeling After Myocardial Infarction: Pathophysiology and Therapy
Sutton, M. G. S. J., & Sharpe, N. (2000) · Circulation · doi:10.1161/01.cir.101.25.2981 · Cited by 1,824
Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771
Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Granger, C. B., McMurray, J. J., Yusuf, S., Held, P., Michelson, E. L., Olofsson, B., Östergren, J., Pfeffer, M. A., & Swedberg, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14284-5 · Cited by 1,686
Pitt, B., Segal, R., Martinez, F. A., Meurers, G., Cowley, A. J., Thomas, I., Deedwania, P. C., Ney, D. E., Snavely, D. B., & Chang, P. I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01187-2 · Cited by 1,665
Mann, J. F., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,589
Mann, J. F. E., Gerstein, H. C., Pogue, J., Bosch, J., Yusuf, S., & for the HOPE Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00007 · Cited by 1,372
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
Parving, H.-H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Desai, A. S., Nicolaides, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208799 · Cited by 1,319
Weiner, D. E., Tighiouart, H., Amin, M. G., Stark, P. C., MacLeod, B., Griffith, J. L., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000123691.46138.e2 · Cited by 1,176
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
Estacio, R. O., Jeffers, B. W., Hiatt, W. R., Biggerstaff, S. L., Gifford, N., & Schrier, R. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381003 · Cited by 1,166
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., Christ-Schmidt, H., Goldsberry, A., Houser, M., Krauth, M., Lambers Heerspink, H. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306033 · Cited by 1,030
Preventing Microalbuminuria in Type 2 Diabetes
Ruggenenti, P., Fassi, A., Ilieva, A. P., Bruno, S., Iliev, I. P., Brusegan, V., Rubis, N., Gherardi, G., Arnoldi, F., Ganeva, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042167 · Cited by 1,020
de Zeeuw, D., Remuzzi, G., Parving, H.-H., Keane, W. F., Zhang, Z., Shahinfar, S., Snapinn, S., Cooper, M. E., Mitch, W. E., & Brenner, B. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00653.x · Cited by 975
Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
The EVOLVE Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205624 · Cited by 971
Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
Hillege, H. L., Nitsch, D., Pfeffer, M. A., Swedberg, K., McMurray, J. J. V., Yusuf, S., Granger, C. B., Michelson, E. L., Östergren, J., Cornel, J. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.580506 · Cited by 945
Wen, C. P., Cheng, T. Y. D., Tsai, M. K., Chang, Y. C., Chan, H. T., Tsai, S. P., Chiang, P. H., Hsu, C. C., Sung, P. K., Hsu, Y. H., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60952-6 · Cited by 920
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
Barnett, A. H., Bain, S. C., Bouter, P., Karlberg, B., Madsbad, S., Jervell, J., & Mustonen, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042274 · Cited by 910
Gansevoort, R. T., Matsushita, K., van der Velde, M., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., & Coresh, J. (2011) · Kidney International · doi:10.1038/ki.2010.531 · Cited by 883
Schrier, R. W., Estacio, R. O., Esler, A., & Mehler, P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00213.x · Cited by 851
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792
Ravid, M., Savin, H., Jutrin, I., Bental, T., Katz, B., & Lishner, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-8-199304150-00001 · Cited by 775
Nephropathy in Patients with Type 2 Diabetes Mellitus
Ritz, E., & Orth, S. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411506 · Cited by 757
Casas, J. P., Chua, W., Loukogeorgakis, S., Vallance, P., Smeeth, L., Hingorani, A. D., & MacAllister, R. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67814-2 · Cited by 745
Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
Appel, L. J., Wright, J. T., Greene, T., Agodoa, L. Y., Astor, B. C., Bakris, G. L., Cleveland, W. H., Charleston, J., Contreras, G., Faulkner, M. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910975 · Cited by 719
Kunz, R., Friedrich, C., Wolbers, M., & Mann, J. F. E. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-1-200801010-00190 · Cited by 717
Efficacy and Safety of Benazepril for Advanced Chronic Renal Insufficiency
Hou, F. F., Zhang, X., Zhang, G. H., Xie, D., Chen, P. Y., Zhang, W. R., Jiang, J. P., Liang, M., Wang, G. B., Liu, Z. R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053107 · Cited by 710
(2000) · PubMed · Cited by 691
Ruggenenti, P., Perna, A., Loriga, G., Ganeva, M., Ene-Iordache, B., Turturro, M., Lesti, M., Perticucci, E., Chakarski, I. N., Leonardis, D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71082-5 · Cited by 644
Kasiske, B. L., Kalil, R. S. N., Ma, J. Z., Liao, M., & Keane, W. F. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-2-199301150-00009 · Cited by 594
Ruggenenti, P., Perna, A., Gherardi, G., Gaspari, F., Benini, R., & Remuzzi, G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04433-x · Cited by 574
Dinneen, S. F. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440340025002 · Cited by 574
Wachtell, K., Ibsen, H., Olsen, M. H., Borch-Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlf, B., Devereux, R. B., Beevers, G., de Faire, U., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00008 · Cited by 557
Treatment of Hypertension in Adults With Diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s80 · Cited by 497
Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures: A HOPE Substudy
Svensson, P., de Faire, U., Sleight, P., Yusuf, S., & Östergren, J. (2001) · Hypertension · doi:10.1161/hy1101.099502 · Cited by 491
Mathiesen, E. R., Hommel, E., Giese, J., & Parving, H. H. (1991) · BMJ · doi:10.1136/bmj.303.6794.81 · Cited by 464
Berl, T., Hunsicker, L. G., Lewis, J. B., Pfeffer, M. A., Porush, J. G., Rouleau, J.-L., Drury, P. L., Esmatjes, E., Hricik, D., Parikh, C. R., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-7-200304010-00010 · Cited by 402
Strippoli, G. F. M., Craig, M., Deeks, J. J., Schena, F. P., & Craig, J. C. (2004) · BMJ · doi:10.1136/bmj.38237.585000.7c · Cited by 385
Viberti, G. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510280037029 · Cited by 381
Rapid Kidney Function Decline and Mortality Risk in Older Adults
Rifkin, D. E., Shlipak, M. G., Katz, R., Fried, L. F., Siscovick, D., Chonchol, M., Newman, A. B., & Sarnak, M. J. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.20.2212 · Cited by 375
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
Marre, M., Chatellier, G., Leblanc, H., Guyene, T. T., Menard, J., & Passa, P. (1988) · BMJ · doi:10.1136/bmj.297.6656.1092 · Cited by 373
Mortality Risk Stratification in Chronic Kidney Disease: One Size for All Ages?
O’Hare, A. M., Bertenthal, D., Covinsky, K. E., Landefeld, C. S., Sen, S., Mehta, K., Steinman, M. A., Borzecki, A., & Walter, L. C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090986 · Cited by 343
The Number, Quality, and Coverage of Randomized Controlled Trials in Nephrology
Strippoli, G. F. M., Craig, J. C., & Schena, F. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000100125.21491.46 · Cited by 343
The ACE Inhibitors in Diabetic Nephropathy Trialist Group* (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-5-200103060-00009 · Cited by 343
Zannad, F., Kessler, M., Lehert, P., Grünfeld, J. P., Thuilliez, C., Leizorovicz, A., Lechat, P., & for the Fosidial Investigators (2006) · Kidney International · doi:10.1038/sj.ki.5001657 · Cited by 332
Ravid, M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440030080010 · Cited by 314
Marre, M., Lievre, M., Chatellier, G., Mann, J. F. E., Passa, P., & Ménard, J. (2004) · BMJ · doi:10.1136/bmj.37970.629537.0d · Cited by 296
Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function
Luo, J., Brunelli, S. M., Jensen, D. E., & Yang, A. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01730215 · Cited by 288
Rapid Decline of Kidney Function Increases Cardiovascular Risk in the Elderly
Shlipak, M. G., Katz, R., Kestenbaum, B., Siscovick, D., Fried, L., Newman, A., Rifkin, D., & Sarnak, M. J. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009050546 · Cited by 287
Cheng, J., Zhang, W., Zhang, X., Han, F., Li, X., He, X., Li, Q., & Chen, J. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.348 · Cited by 280
Laffel, L. M. B., McGill, J. B., & Gans, D. J. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80226-5 · Cited by 279
Change in Estimated GFR Associates with Coronary Heart Disease and Mortality
Matsushita, K., Selvin, E., Bash, L. D., Franceschini, N., Astor, B. C., & Coresh, J. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009010025 · Cited by 276
The Paradox of the Low-Renin State in Diabetic Nephropathy
PRICE, D. A., PORTER, L. E., GORDON, M., FISHER, N. D. L., DE'OLIVEIRA, J. M. F., LAFFEL, L. M. B., PASSAN, D. R., WILLIAMS, G. H., & HOLLENBERG, N. K. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10112382 · Cited by 272
Strippoli, G. F., Bonifati, C., Craig, M. E., Navaneethan, S. D., & Craig, J. C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006257 · Cited by 265
Blood Pressure Lowering Treatment Trialists' Collaboration (2013) · BMJ · doi:10.1136/bmj.f5680 · Cited by 263
Marre, M., Leblanc, H., Suarez, L., Guyenne, T. T., Menard, J., & Passa, P. (1987) · BMJ · doi:10.1136/bmj.294.6585.1448 · Cited by 261
Mehler, P. S., Coll, J. R., Estacio, R., Esler, A., Schrier, R. W., & Hiatt, W. R. (2003) · Circulation · doi:10.1161/01.cir.0000049640.46039.52 · Cited by 254
Hou, F. F., Xie, D., Zhang, X., Chen, P. Y., Zhang, W. R., Liang, M., Guo, Z. J., & Jiang, J. P. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121372 · Cited by 251
Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis
Lambers Heerspink, H. J., Kröpelin, T. F., Hoekman, J., & de Zeeuw, D. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070688 · Cited by 242
Wu, H.-Y., Huang, J.-W., Lin, H.-J., Liao, W.-C., Peng, Y.-S., Hung, K.-Y., Wu, K.-D., Tu, Y.-K., & Chien, K.-L. (2013) · BMJ · doi:10.1136/bmj.f6008 · Cited by 233
Lacourcière, Y., Bélanger, A., Godin, C., Hallé, J.-P., Ross, S., Wright, N., & Marion, J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00224.x · Cited by 229
Ahmed, A. K., Kamath, N. S., El Kossi, M., & El Nahas, A. M. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp511 · Cited by 226
Self-citationAcute Kidney Injury in Elderly Persons
Coca, S. G. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.034 · Cited by 226
Black, C., Sharma, P., Scotland, G., McCullough, K., McGurn, D., Robertson, L., Fluck, N., MacLeod, A., McNamee, P., Prescott, G., et al. (2010) · Health Technology Assessment · doi:10.3310/hta14210 · Cited by 222
Ruggenenti, P., Perna, A., & Remuzzi, G. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12122832 · Cited by 220
Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection
Bakris, G. L., Barnhill, B. W., & Sadler, R. (1992) · Kidney International · doi:10.1038/ki.1992.139 · Cited by 219
Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
Lebovitz, H. E., Wiegmann, T. B., Cnaan, A., Shahinfar, S., Sica, D. A., Broadstone, V. L., Schwartz, S. L., Mengel, M. C., Segal, R., & Versaggi, J. A. (1994) · PubMed · Cited by 219
Hsu, T.-W., Liu, J.-S., Hung, S.-C., Kuo, K.-L., Chang, Y.-K., Chen, Y.-C., Hsu, C.-C., & Tarng, D.-C. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12700 · Cited by 216
Morimoto, T., Gandhi, T. K., Fiskio, J. M., Seger, A. C., So, J. W., Cook, E. F., Fukui, T., & Bates, D. W. (2004) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2003.00484.x · Cited by 211
Ansell, D., Roderick, P., Hodsman, A., Ford, D., Steenkamp, R., & Tomson, C. (2009) · Nephron Clinical Practice · doi:10.1159/000209996 · Cited by 200
Ahmad, J., Siddiqui, M. A., & Ahmad, H. (1997) · Diabetes Care · doi:10.2337/diacare.20.10.1576 · Cited by 198
Effect of Telmisartan on Renal Outcomes: A Randomized Trial
Mann, J. F. E., Schmieder, R. E., Dyal, L., McQueen, M. J., Schumacher, H., Pogue, J., Wang, X., Probstfield, J. L., Avezum, A., Cardona-Munoz, E., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-1-200907070-00122 · Cited by 196
Mathiesen, E. R., Hommel, E., Hansen, H. P., Smidt, U. M., & Parving, H.-H. (1999) · BMJ · doi:10.1136/bmj.319.7201.24 · Cited by 192
Bangalore, S., Fakheri, R., Toklu, B., & Messerli, F. H. (2016) · BMJ · doi:10.1136/bmj.i438 · Cited by 183
Savage, S., Estacio, R. O., Jeffers, B., & Schrier, R. W. (1996) · Diabetes Care · doi:10.2337/diacare.19.11.1243 · Cited by 176
Parving, H. H., Hommel, E., Damkjaer Nielsen, M., & Giese, J. (1989) · BMJ · doi:10.1136/bmj.299.6698.533 · Cited by 171
Knight, E. L., Glynn, R. J., McIntyre, K. M., Mogun, H., & Avorn, J. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70009-8 · Cited by 166
Landray, M. J., Emberson, J. R., Blackwell, L., Dasgupta, T., Zakeri, R., Morgan, M. D., Ferro, C. J., Vickery, S., Ayrton, P., Nair, D., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.07.016 · Cited by 165
Molnar, M. Z., Kalantar-Zadeh, K., Lott, E. H., Lu, J. L., Malakauskas, S. M., Ma, J. Z., Quarles, D. L., & Kovesdy, C. P. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.050 · Cited by 163
Penno, G., Chaturvedi, N., Talmud, P. J., Cotroneo, P., Manto, A., Nannipieri, M., Luong, L. A., & Fuller, J. H. (1998) · Diabetes · doi:10.2337/diabetes.47.9.1507 · Cited by 159
Identifying patients with chronic kidney disease from general practice computer records
de Lusignan, S., Chan, T., Stevens, P. E., et al. (2005) · Family Practice · doi:10.1093/fampra/cmi026 · Cited by 153
Antihypertensive agents for preventing diabetic kidney disease
Lv, J., Perkovic, V., Foote, C., Craig, M. E., Craig, J. C., & Strippoli, G. F. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004136.pub3 · Cited by 148
Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study
Neovius, M., Jacobson, S. H., Eriksson, J. K., Elinder, C., & Hylander, B. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004251 · Cited by 141
Bhandari, S., Ives, N. J., Brettell, E. A., Valente, M., Cockwell, P., Topham, P., Cleland, J. G. F., Khwaja, A., & Nahas, M. E. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv346 · Cited by 133
Self-citationCrepaldi, G., Carta, Q., Deferrari, G., Mangili, R., Navalesi, R., Santeusanio, F., Spalluto, A., Vanasia, A., Villa, G., Nosadini, R., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.104 · Cited by 124
Remuzzi, G., Ruggenenti, P., Perna, A., Dimitrov, B. D., de Zeeuw, D., Hille, D. A., Shahinfar, S., Carides, G. W., & Brenner, B. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000146423.71226.0c · Cited by 123
GFR Decline and Mortality Risk among Patients with Chronic Kidney Disease
Perkins, R. M., Bucaloiu, I. D., Kirchner, H. L., Ashouian, N., Hartle, J. E., & Yahya, T. M. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00470111 · Cited by 123
Estacio, R. O., & Schrier, R. W. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00750-4 · Cited by 122
Sano, T., Kawamura, T., Matsumae, H., Sasaki, H., Nakayama, M., Hara, T., Matsuo, S., Hotta, N., & Sakamoto, N. (1994) · Diabetes Care · doi:10.2337/diacare.17.5.420 · Cited by 120
McInnes, G. T. (2003) · The British Journal of Diabetes · doi:10.1177/14746514030030040501 · Cited by 117
Rizzoni, D., Porteri, E., Ciuceis, C. D., Sleiman, I., Rodella, L. F., Rezzani, R., Paiardi, S., Bianchi, R., Ruggeri, G., Boari, G. E. M., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000153308.91043.97 · Cited by 116
Cordonnier, D., Pinel, N., Barro, C. D., Maynard, C., Zaoui, P., Halimi, S., de Ligny, B. H., Reznic, Y., Simon, D., & Bilous, R. W. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061253 · Cited by 112
O'Hare, P. J., Bilbous, R., Mitchell, T., Callaghan, C. J. O., Viberti, G. C., & Ace-Inhibitor Trial to Lower Albuminuria in Normotensive Insulin-Dependent Subjects Study Group (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1823 · Cited by 109
Parving, H., Hommel, E. E., Jensen, B. R., & Hansen, H. P. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00790.x · Cited by 104
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Haller, H. G., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2012) · Survey of Anesthesiology · doi:10.1097/01.sa.0000412361.12996.3b · Cited by 104
Manabe, S., Okura, T., Watanabe, S., Fukuoka, T., & Higaki, J. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000185783.00391.60 · Cited by 102
Ravid, M., Neumann, L., & Lishner, M. (1995) · Kidney International · doi:10.1038/ki.1995.135 · Cited by 100
Appropriate Blood Pressure Control in NIDDM (ABCD) Trial
Schrier, R. W., Estacio, R. O., & Jeffers, B. (1996) · Diabetologia · doi:10.1007/s001250050629 · Cited by 93
Massie, B. M., Armstrong, P. W., Cleland, J. G. F., Horowitz, J. D., Packer, M., Poole-Wilson, P. A., & Rydén, L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.2.165 · Cited by 91
Parving, H. H., Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · PubMed · Cited by 86
Jerums, G., Allen, T. J., Campbell, D. J., Cooper, M. E., Gilbert, R. E., Hammond, J. J., Jf, R., & Tsalamandris, C. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(05)80003-4 · Cited by 85
Pleiotropic effects of type 2 diabetes management strategies on renal risk factors
Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M. H. H., Heerspink, H. J. L., & van Raalte, D. H. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00030-3 · Cited by 85
Stornello, M., Valvo, E. V., & Scapellato, L. (1989) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198912000-00009 · Cited by 84
Chronic Kidney Disease: Common, Harmful and Treatable – World Kidney Day 2007
Levey, A. S., Andreoli, S. P., DuBose, T. D., Provenzano, R., & Collins, A. J. (2007) · American Journal of Nephrology · doi:10.1159/000099801 · Cited by 84
Trevisan, R., & Tiengo, A. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00162-i · Cited by 83
Sano, T., Hotta, N., Kawamura, T., Matsumae, H., Chaya, S., Sasaki, H., Nakayama, M., Hara, T., Matsuo, S., & Sakamoto, N. (1996) · Diabetic Medicine · Cited by 78
Kovesdy, C. P., & Anderson, J. E. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00335.x · Cited by 70
Chan, K. E., Ikizler, T. A., Gamboa, J. L., Yu, C., Hakim, R. M., & Brown, N. J. (2011) · Kidney International · doi:10.1038/ki.2011.228 · Cited by 68
Chase, H. P., Garg, S. K., Harris, S., Hoops, S., Jackson, W. E., & Holmes, D. L. (1993) · PubMed · Cited by 68
Bakris, G. L., Slataper, R., Vicknair, N., & Sadler, R. (1994) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(94)90003-5 · Cited by 67
Katayama, S., Kikkawa, R., ISOGAI, S., Sasaki, N., Matsuura, N., Tajima, N., Urakami, T., Uchigata, Y., & Ohashi, Y. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00289-3 · Cited by 59
Antihypertensive agents for preventing diabetic kidney disease
Strippoli, G. F., Craig, M. E., Craig, J. C., Lv, J., & Perkovic, V. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004136.pub2 · Cited by 59
Nankervis, A. J., Nicholls, K., Kilmartin, G., Allen, P., Ratnaike, S., & Martin, F. I. R. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90364-x · Cited by 56
Tan, K. C. B., Chow, W., Ai, V. H. G., & Lam, K. S. L. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.255 · Cited by 54
Tütüncü, N. B., Gürlek, A., & Gedik, O. (2001) · Acta Diabetologica · doi:10.1007/s592-001-8073-2 · Cited by 53
The European Study for the Prevention of Renal Disease in Type 1 Diabetes ESPRIT Study Group (2001) · Diabetes · doi:10.2337/diabetes.50.4.843 · Cited by 52
Romero, R., Salinas, I., Lucas, A., Abad, E., Reverter, J. L., Johnston, S., & Sanmartí, A. (1993) · Diabetes Care · doi:10.2337/diacare.16.4.597 · Cited by 45
Baseline characteristics of participants in the appropriate blood pressure control in diabetes trial
Estacio, R. O., Savage, S., Nagel, N. J., et al. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00154-9 · Cited by 44
Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.
O'Donnell, M. J., Rowe, B. R., Lawson, N., Horton, A., Gyde, O. H., & Barnett, A. H. (1993) · PubMed · Cited by 40
Bojestig, M., Karlberg, B. E., Lindström, T., & Nyström, F. H. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.919 · Cited by 40
Ahmad, J., Shafique, S., Abidi, S. M. A., & Parwez, I. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00016-0 · Cited by 33
Jerums, G., Allen, T. J., Campbell, D. J., Cooper, M. E., Gilbert, R. E., Hammond, J. J., O’Brien, R. C., Jf, R., Tsalamandris, C., & The Melbourne Diabetic Nephropathy Study Group (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01316.x · Cited by 32
Mogensen, C. E. (1995) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(95)80036-e · Cited by 31
Stornello, M., Valvo, E. V., & Scapellato, L. (1992) · Clinical Science · doi:10.1042/cs0820019 · Cited by 30
Drug Treatment for Hypertensive Patients in Special Situations: Diabetes and Hypertension
Mogensen, C. E. (1999) · Clinical and Experimental Hypertension · doi:10.3109/10641969909061018 · Cited by 28
Poulsen, P. L., Ebbehøj, E., & Mogensen, C. E. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00821.x · Cited by 27
Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease
Bhandari, S. (2010) · Frontiers in bioscience · doi:10.2741/3794 · Cited by 26
Self-citationPoulsen, P. L., Ebbehøj, E., Nosadini, R., Fioretto, P., Deferrari, G., Crepaldi, G., & Ce, M. (2001) · PubMed · Cited by 24
Hansen, K. W., Klein, F., Christensen, P. D., Sørensen, K. E., Andersen, P. H., Moller, J. H., Pedersen, E. B., Christiansen, J. S., & Mogensen, C. E. (1994) · PubMed · Cited by 22
Sato, A., Tabata, M., Hayashi, K., et al. (2003) · Clinical and Experimental Nephrology · doi:10.1007/s10157-003-0227-1 · Cited by 19
Jain, P., Cockwell, P., Little, J., Ferring, M., Nicholas, J., Richards, N. N., Higgins, R. M., & Smith, S. A. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp455 · Cited by 19
Capek, M., Schnack, C., Ludvik, B. H., Kautzky‐Willer, A., Banyai, M., & Prager, R. (1994) · Journal of Molecular Medicine · doi:10.1007/bf00577736 · Cited by 18
Possible effect of angiotensin-converting enzyme inhibition on glomerular charge selectivity
Hansen, P. M., Mathiesen, E. R., Kofoed‐Enevoldsen, A., & Deckert, T. (1995) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(94)00026-k · Cited by 17
Zhang, G., Hou, F. F., Zhang, X., & Liu, Q.-F. (2005) · PubMed · Cited by 16
Ko, G. T. C., Tsang, C.-C., & Chan, H. C.-K. (2005) · Advances in Therapy · doi:10.1007/bf02849886 · Cited by 14
Diabetic microalbuminuria and cilazapril.
Phillips, P. J. J., Phillipou, G., Bowen, K. M., LOWE, J. M., Yue, D. K., WISCHUSEN, J., & de Pater, G. (1993) · PubMed · Cited by 13
Remuzzi, G., Tognoni, G., Ruggenenti, P., Perna, A., Maggiorre, Q., Pizzarelli, F., Schena, F., Mecca, G., Daina, E., Maiorca, G., et al. (1991) · Journal of Nephrology · Cited by 13
Shih, C.-J., Chu, H., Ou, S., & Chen, Y. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.07.053 · Cited by 11
Carella, M. J., Gossain, V. V., & Jones, J. E. (1999) · PubMed · Cited by 8
Microalbuminuria and ACE inhibition in non-hypertensive diabetics
Marre, M. (1990) · Journal of Diabetes and its Complications · doi:10.1016/0891-6632(90)90042-4 · Cited by 6
Prognosis of diabetic patients post-MI: The role of ACE inhibitor treatment
Zuanetti, G. (1996) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(96)00027-x · Cited by 5
Research works printed but not linked: 3
- 10.1159/000370275 · doi:10.1159/000370275
- 10.1093/ndt/gfq505 · doi:10.1093/ndt/gfq505
- 10.1159/000381477 · doi:10.1159/000381477
Cited by
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O. M., Afarideh, M., Agarwal, S. K., Agudelo-Botero, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30045-3 · Cited by 6,648
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Metadata
- Authors
- Ahmed, A., Jorna, T., & Bhandari, S.
- Venue
- Nephron
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 133
- Issue
- 3
- Pages
- 147-158
- ISSN
- 1660-8151 (ISSN-L)
- 2235-3186
- OpenAlex
- W2475261460
- Cited by
- 11,717
- References
- 170
- FWCI
- 957.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.